Early mortality critically impedes improvements in thyroid cancer survival through a half century

CONCLUSIONS: We documented worse relative survival in the first year than in the 4 subsequent years, most likely because of rare anaplastic cancer. Overall survival in thyroid cancer patients increased in the Nordic countries in the course of 50 years; 5-year survival was close to 90% for men and close to 95% for women. Even though overdiagnosis may explain some of 5-year survival increase, it is unlikely to influence the substantial increase in 1-year survival. The unmet need is to increase 1-year survival by diagnosing and treating aggressive tumors before metastatic spread.PMID:37675794 | DOI:10.1093/ejendo/lvad117
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Source Type: research